Get the Stockscreener App
0.489
2.20%
-0.011
Pre-market:
.46
-0.029
-5.93%
Cosmos Health Inc stock is traded at $0.489, with a volume of 114.11K.
It is down -2.20% in the last 24 hours and down -23.59% over the past month.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
See More
Previous Close:
$0.50
Open:
$0.511
24h Volume:
114.11K
Relative Volume:
0.29
Market Cap:
$11.37M
Revenue:
$56.04M
Net Income/Loss:
$-20.39M
P/E Ratio:
-0.2004
EPS:
-2.44
Net Cash Flow:
$-6.84M
1W Performance:
+1.33%
1M Performance:
-23.59%
6M Performance:
-49.16%
1Y Performance:
-35.83%
1-Day Range:
$0.48
$0.511
1-Week Range:
$0.4501
$0.5298
52-Week Range:
$0.4501
$1.58
Cosmos Health Inc Stock (COSM) Company Profile
Name
Cosmos Health Inc
Sector
Industry
Phone
312-536-3102
Address
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
Compare COSM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COSM
Cosmos Health Inc
|
0.489 | 11.37M | 56.04M | -20.39M | -6.84M | -2.44 |
|
MCK
Mckesson Corporation
|
643.69 | 80.67B | 344.58B | 2.83B | 1.63B | 21.84 |
|
COR
Cencora Inc
|
256.01 | 49.59B | 303.19B | 1.40B | -638.10M | 7.03 |
|
CAH
Cardinal Health Inc
|
126.27 | 30.76B | 222.16B | 1.31B | -486.00M | 5.36 |
|
HSIC
Henry Schein Inc
|
69.81 | 9.32B | 12.50B | 314.00M | 421.00M | 2.44 |
|
PDCO
Patterson Companies Inc
|
31.14 | 2.73B | 6.55B | 155.22M | -823.13M | 1.71 |
Cosmos Health Inc Stock (COSM) Latest News
Cosmos Health CEO acquires $44,999 in stock through debt exchange By Investing.com - Investing.com South Africa
Cosmos Health CEO acquires $44,999 in stock through debt exchange - Investing.com
Cosmos health CEO acquires shares worth $65,000 in debt exchange By Investing.com - Investing.com Australia
Cosmos Holdings stock hits 52-week low at $0.46 - Investing.com India
Cosmos health CEO acquires shares worth $65,000 in debt exchange - Investing.com
Cosmos Health CEO Acquires Over 130K Shares Through Debt Exchange - TradingView
Cosmos Health Inc. (NASDAQ:COSM) Might Not Be As Mispriced As It Looks After Plunging 31% - Simply Wall St
Cosmos Holdings stock hits 52-week low at $0.46 By Investing.com - Investing.com Canada
Cosmos Health Actively Exploring Spinoff of R&D Division into a Publicly Listed Standalone Biotech Company - ACCESS Newswire
Cosmos Health expands distribution of Avian Influenza kits - MSN
Cosmos Holdings Inc. Changes its Name to Cosmos Health Inc. and Announces a 1-For-25 Reverse Stock Split - ACCESS Newswire
Cosmos Health Expands Sky Premium Life Nutraceuticals Brand with 60 New SKUs as Global Growth Accelerates - ACCESS Newswire
Cosmos Health CEO Grigorios Siokas acquires $200,000 in stock By Investing.com - Investing.com Canada
Cosmos Health CEO Grigorios Siokas acquires $200,000 in stock - Investing.com India
Cosmos Health CEO Acquires Shares Through Debt Exchange Agreement - TradingView
Bullish Cosmos Health Insiders Loaded Up On US$539.0k Of Stock - Yahoo Finance
Cosmos Health postpones securities offering By Investing.com - Investing.com South Africa
Cosmos Health postpones securities offering - Investing.com India
Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1 - ACCESS Newswire
Strategic Shift: Cosmos Health Postpones Capital Raise, Prioritizes Annual Report - StockTitan
Cosmos Health Inc. (NASDAQ:COSM) Short Interest Down 39.7% in January - Defense World
Cosmos Health advances weight management device to clinical trials - MSN
Cosmos health CEO Grigorios Siokas acquires shares worth $29,999 - MSN
Cosmos Health Inc. (COSM) Expands IP Portfolio with AI-Driven Drug Repurposing Patents - Yahoo Finance
Cosmos Health files patents for cancer treatments By Investing.com - Investing.com Australia
Cosmos Health advances weight management device to clinical trials By Investing.com - Investing.com South Africa
Cosmos Health Enters Final Development Phase of CCX0722 Weight M - WICZ
Cosmos Health Enters Final Development Phase of CCX0722 Weight Management Solution; Expected Product Launch in Q1 or Q2 2026, Gaining Access to Over $142 Billion Market - ACCESS Newswire
Cosmos Health's Novel Weight Loss Device Enters Clinical Phase, Eyes Massive $142B Market Opportunity - StockTitan
Cosmos Health files patents for cancer treatments - Investing.com India
Cosmos Health Advances Cancer Treatment Innovation with Two New AI-Driven Patent Filings for Gliomas and Hematologic Malignancies; $25 Billion+ Global Market - ACCESS Newswire
AI Breakthrough: Cosmos Health's Dual Cancer Patents Could Revolutionize $25B Treatment Market - StockTitan
Cosmos Health Appoints Dimitris Moraitis as Vice President of Strategy & Operations - citybiz
Cosmos Health Strengthens Management Team with the Appointment o - WICZ
Cosmos Health Strengthens Management Team with the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy & Operations - ACCESS Newswire
Analyzing Ratios: Cosmos Health Inc (COSM)’s Financial Story Unveiled - The Dwinnex
Cosmos Health secures a 10-year contract with Provident - MSN
Cosmos Health Requests Appeal from the Nasdaq Stock Market - ACCESS Newswire
Cosmos Health Inc (NASDAQ: COSM) Up 32.86% From 52-Week Low; YTD Jumps 4.63% – Here’s What To Do Now - Marketing Sentinel
Cosmos Health secures a 10-year contract with Provident By Investing.com - Investing.com South Africa
Cosmos Health Pockets 10-Year Manufacturing Deal With Provident Pharmaceuticals - AOL
Cosmos Health Inc Stock (COSM) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.45%
0.64%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):